SCHEDULE 13G/A: Dodge & Cox Discloses 10.1% Stake in Baxter International Inc.
Beneficial Ownership Disclosure
Investment adviser Dodge & Cox has filed an amended Schedule 13G, revealing a 10.1% beneficial ownership stake in Baxter International Inc. as of February 28, 2025.
Summary
- Dodge & Cox, an investment adviser, has filed an Amendment No. 3 to Schedule 13G regarding its ownership in Baxter International Inc.
- As of February 28, 2025, Dodge & Cox beneficially owns an aggregate of 51,581,409 shares of Baxter International Inc. Common Stock.
- This represents 10.1% of the total class of securities.
- Dodge & Cox holds sole voting power over 48,813,709 shares and sole dispositive power over 51,581,409 shares.
- A significant portion of this ownership, specifically 35,272,400 shares (6.9% of the class), is held by Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940.
- The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The filing itself is a routine disclosure of ownership, but a significant stake by a reputable investment adviser like Dodge & Cox can be viewed as a positive signal of institutional confidence in the company, without implying any control intent.
Positives
- Dodge & Cox, a reputable investment adviser, holds a significant 10.1% stake, indicating institutional confidence in Baxter International Inc.
Future Outlook
NA
Industry Context
This filing indicates continued institutional interest in the healthcare and medical device sector, represented by Baxter International Inc., from a major investment adviser.
Stakeholder Impact
- Shareholders: Increased institutional ownership by a major investment adviser may be viewed positively, potentially signaling confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of event which requires filing of this statement, indicating when the ownership threshold was met or changed. |
| 03/07/2025 | Date of filing and signature by Dodge & Cox's Chief Compliance Officer. |
Keywords
Baxter International Inc., Dodge & Cox, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Medical Devices, Healthcare, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.